Mercator Medical (FRA:MM2) GF Score: 60/100 (As of Jul. 01, 2026) — Near Median


FRA:MM2 Mercator Medical SA FRA:MM2
60 GF Score
Price €10.96
GF Value €10.64
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Mercator Medical GF Score?

Mercator Medical FRA:MM2 -0.18% 60 GF Score is 60 as of Jul. 01, 2026, which is 9% below its 10-year median of 66.00. GuruFocus rates FRA:MM2 with a GF Score™ of 60/100 and a GF Value™ of €10.64 (Fairly Valued). The stock has 2 warning signs investors should review.

Mercator Medical has the GF Score of 60, which implies that the company might have Poor future performance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 8/10
2. Profitability Rank : 4/10
3. Growth Rank : 1/10
4. GF Value Rank : 9/10
5. Momentum Rank : 3/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Mercator Medical might have Poor future performance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Mercator Medical  (FRA:MM2) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Mercator Medical GF Score Related Terms

FRA:MM2 vs ISRG, BDX, MDLN: GF Score Comparison

For the Medical Instruments & Supplies subindustry, Mercator Medical's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mercator Medical GF Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mercator Medical's GF Score distribution charts can be found below:

* The bar in red indicates where Mercator Medical's GF Score falls into.


FRA:MM2
60GF Score
Mercator Medical SA FRA:MM2
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 60 mean?
Mercator Medical (FRA:MM2) has a GF Score of 60 as of Jul. 01, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Mercator Medical and its competitors. This is near median its historical median of 66.00. Over the past decade, Mercator Medical's GF Score has ranged from 28.00 to 81.00.
Is Mercator Medical's GF Score too high?
Mercator Medical's current GF Score of 60 is near median its 10-year median of 66.00. Over the past 10 years, this metric has ranged from a low of 28.00 to a high of 81.00. Overall, Mercator Medical has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's GF Score compare to ISRG and BDX?
Mercator Medical's GF Score of 60 can be compared against companies in the Medical Devices & Instruments industry. Historically, Mercator Medical's own GF Score has ranged from 28.00 to 81.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Mercator Medical and its competitors. Mercator Medical's current GF Score is 60, which is near median its own 10-year median of 66.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (FRA:MM2) is currently considered Fairly Valued. The stock's GF Value™ is €10.64, compared to a current price of €10.96 — trading 3% above its estimated fair value. The current GF Score is 60, which is near median its 10-year median of 66.00. Mercator Medical's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current GF Score is 60 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (FRA:MM2) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be overvalued. The current stock price of €10.96 is trading 3% above its estimated GF Value™ of €10.64. GuruFocus considers Mercator Medical to be Fairly Valued.

Key valuation signals for FRA:MM2:

  • GF Score: 60 (near median its 10-year median of 66.00)
  • GF Value™: €10.64 vs. price of €10.96 (3% above fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mercator Medical Business Description

Other Exchanges MRC:Poland
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
60GF Score

Get the complete analysis for FRA:MM2

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.96
Price
€10.64
GF Value